Latest News and Press Releases

Please read the full announcement in PDF Attachment 2024_31_Trading_By_Management ...

Please read the full announcement in PDF Attachment 2024_30_Trading_By_Management ...

Please read the full announcement in PDF Attachment 2024_29_Trading_By_Management ...

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...

In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...

H1 organic pro forma sales growth at 7%, with pro forma adjusted EBITDA margin at 35.3%. Full-year outlook increased.   H1 organic pro forma sales growth of 7% and 8% on IFRS reported basis. Q2...

Novonesis increases its full-year sales and profitability outlook based on the first half year performance coupled with strong momentum going into the first months of the second half.The 2024 outlook...

Please see the full announcement in PDF  Attachments 2024_25_Major_Shareholders_Announcement Novozymes B 13 Aug 2024 Final ...

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold...

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...